Richard Meyer

Pharma has a lot of work to do to “earn trust”

circletrustFresh from a Bloomerg news story comes this tidbit “Gilead Sciences Inc., whose $1,000-a-pill hepatitis C treatment is one of the world’s most expensive drugs, is avoiding billions of dollars in U.S. Taxes by booking profits overseas.” This is pure chutzpah and, it tells American consumers that we are going to put profits ahead of everything else and gives all of pharma a black eye. Continue reading »

Statistics on mobile health mean little

Unknown-1“Nobody has figured out how to make consumers — patients — care about mobile health technologies. “And if we don’t [figure that out], m-health will be another tech bubble”. Dr. Joseph Kvedar, director of the Center for Connected Health. Continue reading »

OMG! Yet another ePharma conference….

UnknownSighas I sit here and read the Tweets from ePharma I am once again reminded why pharma is lagging in digital marketing. I mean to say WebMD is the number one health portal on the web?  Come-on everyone should know that, but what they also should know is that very few people go to WebMD and use that information for treatment decisions. Continue reading »

Entering a new era in DTC marketing

ID-100124225OK, I get it.  DTC marketers have to show ROI to get budgets from bean counter who know the cost of everything but the value of nothing but that approach is going to lead to a decline in DTC marketing effectiveness. Continue reading »

End the myths around DTC marketing

mythsEnough of myths, lies and propaganda that direct to consumer advertising drives consumers to ask for medications they don’t need and want.  In fact, DTC advertising educates, informs and helps patients choose the right treatments for their health needs. Continue reading »

To WebMD or not to WebMD?

screenshot_193POST SUMMARY: WebMD is the number one health portal on the Internet, but is it really required to consider WebMD as part of pharma marketers online media plans?  Not really. Continue reading »

Yet another attack on pharma

caution-mass-confusionPOST SUMMARY: From spending too much on sales and marketing to deception of clinical trials the pharma industry is being attacked by a media that is looking to channel consumer anger rather than explore an unbiased balanced article.  It’s time for the industry to fight back because there are too many really good people working within it to try and help patients lead a better life. Continue reading »

Share with your friends